Report #2826522

Received Feb 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 16 yrs
State: CO
Recovered: Unknown
Vaccinated: Feb 12, 2025
Onset: Feb 12, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
MNQ	MENINGOCOCCAL CONJUGATE (MENVEO)	NOVARTIS VACCINES AND DIAGNOSTICS	UNK	AMXB056A	—

Symptoms (1)

Product preparation issue

Symptom narrative

administration of the diluent portion only of Menveo (2-vial) vaccine; administration of the diluent portion only of Menveo (2-vial) vaccine; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 16-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMXB056A, expiry date 31-DEC-2026) for prophylaxis. On 12-FEB-2025, the patient received Menveo. On 12-FEB-2025, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: administration of the diluent portion only of Menveo (2-vial) vaccine) and inappropriate dose of vaccine administered (Verbatim: administration of the diluent portion only of Menveo (2-vial) vaccine). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK Receipt Date: 12-FEB-2025 The health care professional reported that the inadvertent administration of the diluent portion only of Menveo (2-vial) vaccine to a patient, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.